New ways to save on drugs

It's not just gasoline. Inflation is slamming drugs too, changing the way to find the best deals.

EMAIL  |   PRINT  |   SHARE  |   RSS
 
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)
By Joe Light, Money Magazine

What is your biggest financial concern?
  • Mortgage
  • Retirement
  • College costs
  • Credit card debt
CDs & Money Market
MMA 0.69%
$10K MMA 0.42%
6 month CD 0.94%
1 yr CD 1.49%
5 yr CD 1.93%

Find personalized rates:
 

Rates provided by Bankrate.com.

(Money Magazine) -- We've reached a dubious health milestone: More than half of insured Americans are now taking at least one "maintenance" drug for a chronic condition, according to a recent health industry report.

Meanwhile, the price of brand-name medications rose 2½ times faster than the rate of inflation last year. Here's the news you need to know to avoid the worst of the pain - no clandestine trips to Canada required.

Discounters have become the best inflation hedge

Wal-Mart (WMT, Fortune 500), which in 2006 began selling 30-day supplies of generics for $4 a pop, just rolled out another plan perfect for people who take meds daily and have a high co-pay: a 90-day supply of any of about 350 generics for just $10 (or your co-pay, whichever is less).

Competitors like Target (TGT, Fortune 500) and Kroger quickly matched the price cuts. Some discounters might offer drugs that others don't, so visit their websites to see if your medicine is on their lists.

More employers are insisting you use mail order

Some employers now require workers who fill the same scrip more than three months in a row (basically anyone on a daily regimen) to order 90-day supplies from an approved mail-order company - or receive a lower reimbursement than the pharmacy rate they're used to. At Time Inc. (Money's parent), for example, your pharmacy co-pay rises by 25% after three months. So before you head to Wal-Mart, do the math.

Insurers are raising co-pays on brand-name drugs

Generics have always been cheaper than brand names, but it's gotten even costlier to insist on, say, Prozac rather than fluoxetine. According to the Kaiser Family Foundation, the average co-pay for a 30-day "nonpreferred" brand is now $43, up from $28 in 2001. The average generic co-pay is just $11, so ask your doctor to prescribe the generic equivalent if one exists (it does more than 75% of the time).  To top of page

Send feedback to Money Magazine
Features
They're hiring!These Fortune 100 employers have at least 350 openings each. What are they looking for in a new hire? More
If the Fortune 500 were a country...It would be the world's second-biggest economy. See how big companies' sales stack up against GDP over the past decade. More
Sponsored By:
10 of the most luxurious airline amenity kits When it comes to in-flight pampering, the amenity kits offered by these 10 airlines are the ultimate in luxury More
7 startups that want to improve your mental health From a text therapy platform to apps that push you reminders to breathe, these self-care startups offer help on a daily basis or in times of need. More
5 radical technologies that will change how you get to work From Uber's flying cars to the Hyperloop, these are some of the neatest transportation concepts in the works today. More


Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.